Asia-Pacific (APAC) Generics Market Summary, Competitive Analysis and Forecast to 2027
Summary
Generics in Asia-Pacific industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2017-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- For the purposes of this profile, a generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and branded generics are included in our market scope. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included. The market value is evaluated at ex-factory prices.
- The Asia-Pacific generics market had total revenues of $162.4 billion in 2022, representing a compound annual growth rate (CAGR) of 11.2% between 2017 and 2022.
- Market consumption volume increased with a CAGR of 2.2% between 2017 and 2022, to reach a total of 62.4% in 2022.
- Factors such as accelerating healthcare costs, rising expiration of patents for branded medicines, growing first generic drug approvals, increasing cardiovascular and infectious diseases, and a growing number of generic manufacturers are driving the generics market.
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the generics market in Asia-Pacific
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in Asia-Pacific
- Leading company profiles reveal details of key generics market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Asia-Pacific generics market with five year forecasts by both value and volume
- What was the size of the Asia-Pacific generics market by value in 2022?
- What will be the size of the Asia-Pacific generics market in 2027?
- What factors are affecting the strength of competition in the Asia-Pacific generics market?
- How has the market performed over the last five years?
- Who are the top competitors in Asia-Pacific's generics market?
- 1 Executive Summary
- 1.1. Market value
- 1.2. Market value forecast
- 1.3. Market volume
- 1.4. Market volume forecast
- 1.5. Geography segmentation
- 1.6. Market rivalry
- 1.7. Competitive landscape
- 2 Market Overview
- 2.1. Market definition
- 2.2. Market analysis
- 3 Market Data
- 3.1. Market value
- 3.2. Market volume
- 4 Market Segmentation
- 4.1. Geography segmentation
- 5 Market Outlook
- 5.1. Market value forecast
- 5.2. Market volume forecast
- 6 Five Forces Analysis
- 6.1. Summary
- 6.2. Buyer power
- 6.3. Supplier power
- 6.4. New entrants
- 6.5. Threat of substitutes
- 6.6. Degree of rivalry
- 7 Competitive Landscape
- 7.1. Who are the leading players?
- 7.2. What are the strengths of the leading players?
- 7.3. Have there been any recent developments in the market?
- 8 Company Profiles
- 8.1. Teva Pharmaceutical Industries Limited
- 8.2. Viatris Inc.
- 8.3. Sun Pharmaceutical Industries Ltd
- 8.4. Pfizer Inc.
- 9 Macroeconomic Indicators
- 9.1. Country data
- 10 Appendix
- 10.1. Methodology
- 10.2. Industry associations
- 10.3. Related MarketLine research
- 10.4. About MarketLine
- List of Tables
- Table 1: Asia-Pacific generics market value: $ million, 2017-22
- Table 2: Asia-Pacific generics market volume: %, 2017-22
- Table 3: Asia-Pacific generics market geography segmentation: $ million, 2022
- Table 4: Asia-Pacific generics market value forecast: $ million, 2022-27
- Table 5: Asia-Pacific generics market volume forecast: %, 2022-27
- Table 6: Teva Pharmaceutical Industries Limited: key facts
- Table 7: Teva Pharmaceutical Industries Limited: Annual Financial Ratios
- Table 8: Teva Pharmaceutical Industries Limited: Key Employees
- Table 9: Viatris Inc.: key facts
- Table 10: Viatris Inc.: Annual Financial Ratios
- Table 11: Viatris Inc.: Key Employees
- Table 12: Viatris Inc.: Key Employees Continued
- Table 13: Sun Pharmaceutical Industries Ltd: key facts
- Table 14: Sun Pharmaceutical Industries Ltd: Annual Financial Ratios
- Table 15: Sun Pharmaceutical Industries Ltd: Key Employees
- Table 16: Pfizer Inc.: key facts
- Table 17: Pfizer Inc.: Annual Financial Ratios
- Table 18: Pfizer Inc.: Key Employees
- Table 19: Pfizer Inc.: Key Employees Continued
- Table 20: Asia-Pacific exchange rate, 2018-22
- List of Figures
- Figure 1: Asia-Pacific generics market value: $ million, 2017-22
- Figure 2: Asia-Pacific generics market volume: %, 2017-22
- Figure 3: Asia-Pacific generics market geography segmentation: % share, by value, 2022
- Figure 4: Asia-Pacific generics market value forecast: $ million, 2022-27
- Figure 5: Asia-Pacific generics market volume forecast: %, 2022-27
- Figure 6: Forces driving competition in the generics market in Asia-Pacific, 2022
- Figure 7: Drivers of buyer power in the generics market in Asia-Pacific, 2022
- Figure 8: Drivers of supplier power in the generics market in Asia-Pacific, 2022
- Figure 9: Factors influencing the likelihood of new entrants in the generics market in Asia-Pacific, 2022
- Figure 10: Factors influencing the threat of substitutes in the generics market in Asia-Pacific, 2022
- Figure 11: Drivers of degree of rivalry in the generics market in Asia-Pacific, 2022
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook